Jul. 5 at 3:26 AM
GLMD is running out of time in a good way.
The 90-day definitive agreement window from April 28th ends this month.
You don’t get many biotech plays under
$1 with a
$12+ book value and real M&A potential.
Low float, strong cash, and a clear catalyst. It’s a ticking time bomb in a setup kind of way.
$CABA $ALLR $CNTB $CLRB